NEUROLEPTIC MALIGNANT SYNDROME

被引：18

作者：

RAMPERTAAP, MP

机构：

来源：

SOUTHERN MEDICAL JOURNAL | 1986年 / 79卷 / 03期

关键词：

D O I：

10.1097/00007611-198603000-00018

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：331 / 336

页数：6

共 69 条

[1]

AMDURSKI S, 1983, CURR THER RES CLIN E, V33, P225

[2] ADVERSE REACTIONS IN TREATMENT WITH LITHIUM-CARBONATE AND HALOPERIDOL [J].

BAASTRUP, PC ;

HOLLNAGEL, P ;

SORENSEN, R ;

SCHOU, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (23) :2645-2646

[3]

BERNSTEIN RA, 1979, PSYCHOSOMATICS, V20, P840

[4] THE NEUROLEPTIC MALIGNANT SYNDROME - PRESENTATION AND TREATMENT [J].

BIRKHIMER, LJ ;

DEVANE, CL .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06) :462-465

[5] MALIGNANT HYPERTHERMIA - A STATISTICAL REVIEW [J].

BRITT, BA ;

KALOW, W .

CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1970, 17 (04) :293-+

[6] NEUROLEPTIC MALIGNANT SYNDROME CAUSED BY DOPAMINE-DEPLETING DRUGS IN A PATIENT WITH HUNTINGTON DISEASE [J].

BURKE, RE ;

FAHN, S ;

MAYEUX, R ;

WEINBERG, H ;

LOUIS, K ;

WILLNER, JH .

NEUROLOGY, 1981, 31 (08) :1022-1026

[7]

BYRD JP, 1983, SOUTHERN MED J, V76, P890

[8]

CAROFF SN, 1980, J CLIN PSYCHIAT, V41, P79

[9] LITHIUM-CARBONATE, HALOPERIDOL, AND IRREVERSIBLE BRAIN-DAMAGE [J].

COHEN, WJ ;

COHEN, NH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (09) :1283-1287

[10]

CONNER CS, 1983, DRUG INTELL CLIN PHA, V17, P539

← 1 2 3 4 5 6 7 →